Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Distinct Healthcare HoldingsHKSE:02677 +0.71%9 EBITDA Margin % is 26.43% as of Dec. 2025, which is 12486% above its 10-year median of 0.21. GuruFocus rates HKSE:02677 with a GF Score™ of 9/100. The stock has 3 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Distinct Healthcare Holdings ranks better than 86.77% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Distinct Healthcare Holdings EBITDA Margin % Related Terms
Distinct Healthcare Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02677 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Distinct Healthcare Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Distinct Healthcare Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Distinct Healthcare Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Distinct Healthcare Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Distinct Healthcare Holdings (HKSE:02677) has a EBITDA Margin % of 26.43% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Distinct Healthcare Holdings and its competitors. This is 12486% above median its historical median of 0.21. According to the industry distribution chart, Distinct Healthcare Holdings ranks #88 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 13.2%.
Is Distinct Healthcare Holdings' EBITDA Margin % too high?
Distinct Healthcare Holdings' current EBITDA Margin % of 26.43% is 12486% above median its 10-year median of 0.21. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Distinct Healthcare Holdings' value of 26.43% is 158.1% above this industry median. Based on the distribution chart, Distinct Healthcare Holdings ranks #88 out of 665 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Distinct Healthcare Holdings has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Distinct Healthcare Holdings' EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Distinct Healthcare Holdings ranks #88 out of 665 companies for EBITDA Margin %. This places Distinct Healthcare Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.24. Distinct Healthcare Holdings' value of 26.43% is 158.1% above this benchmark. While the company's 10-year median is 0.21 vs. the industry median of 10.24, Distinct Healthcare Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Distinct Healthcare Holdings's current EBITDA Margin % of 26.43% is 158.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Distinct Healthcare Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Distinct Healthcare Holdings's current EBITDA Margin % is 26.43%, which is 12486% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Distinct Healthcare Holdings stock overvalued right now?
Distinct Healthcare Holdings (HKSE:02677) has a current EBITDA Margin % of 26.43%. The current EBITDA Margin % is 26.43%, which is 12486% above median its 10-year median of 0.21 and 158.1% above the Healthcare Providers & Services industry median of 10.24. Distinct Healthcare Holdings' overall GF Score™ is 9/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Distinct Healthcare Holdings (HKSE:02677), the current EBITDA Margin % is 26.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Distinct Healthcare Holdings Ltd is principally engaged in the provision of healthcare services through healthcare service institutions and tele-healthcare service platform mainly in the People's Republic of China. The company owns and operates healthcare service institutions and tele-healthcare service platform across China, including clinics and hospitals. Additionally, it operates general practice clinics in Singapore and Malaysia. The company derives revenue from providing healthcare services. Geographically, it operates its business mainly in the Chinese Mainland.
9GF Score
Get the complete analysis for HKSE:02677
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02677 has been successfully added to your 
